Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: VASELLA-Daniel

NOVARTIS-ALCON/
RTX2TLE4
November 14, 2016
Daniel Vasella, then-Chairman and Chief Executive Officer of Swiss drugmaker Novartis gestures during...
Basel, Switzerland
Daniel Vasella, then-Chairman and Chief Executive Officer of Novartis gestures during news conference...
Daniel Vasella, then-Chairman and Chief Executive Officer of Swiss drugmaker Novartis gestures during the annual news conference in Basel January 26, 2010. REUTERS/Pascal Lauener/File Photo
NOVARTIS/
RTR3E4E1
February 22, 2013
Swiss drugmaker Novartis CEO Joe Jimenez (L) and Ulrich Lehner, member of the Board of Directors attend...
Basel, Switzerland
Swiss drugmaker Novartis CEO Jimenez and Lehner, member of the Board of Directors attend the the annual...
Swiss drugmaker Novartis CEO Joe Jimenez (L) and Ulrich Lehner, member of the Board of Directors attend the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DY
February 22, 2013
Ulrich Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual...
Basel, Switzerland
Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual shareholders...
Ulrich Lehner, member of the Board of Directors of Swiss drug maker Novartis addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DW
February 22, 2013
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker...
Basel, Switzerland
Designated successor Reinhardt is seen on a huge TV screen as outgoing utgoing Chairman of Swiss drug...
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DT
February 22, 2013
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker...
Basel, Switzerland
Designated successor Reinhardt is seen on a huge TV screen as outgoing utgoing Chairman of Swiss drug...
Designated successor Joerg Reinhardt is seen on a huge TV screen as outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DQ
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the the annual shareholders general...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. On front left sits Ulrich Lehner, Member of the Board of Directors. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DP
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (C) explains a device for voting during...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella explains a device for voting during the the annual...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (C) explains a device for voting during the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E4DM
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the the annual shareholders general...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. On front left sits Ulrich Lehner, Member of the Board of Directors. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E43U
February 22, 2013
Dominique Biedermann, Executive director of Ethos Swiss Foundation for Sustainable Development, asks...
Basel, Switzerland
Biedermann Executive director of Ethos asks questions during the annual shareholders general meeting...
Dominique Biedermann, Executive director of Ethos Swiss Foundation for Sustainable Development, asks questions to outgoing Chairman of Swiss drug maker Novartis Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E43S
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella pauses during the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella pauses during the annual shareholders general...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella pauses during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E43Q
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E422
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E41R
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E41Q
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E41N
February 22, 2013
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella...
Basel, Switzerland
Swiss drugmaker Novartis CEO Jimenez delivers his speech next to outgoing Chairman Vasella during the...
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella (C) during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E41M
February 22, 2013
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella...
Basel, Switzerland
Swiss drugmaker Novartis CEO Jimenez delivers his speech next to outgoing Chairman Vasella during the...
Swiss drugmaker Novartis CEO Joe Jimenez (L) delivers his speech next to outgoing Chairman Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E41J
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH TPX IMAGES OF THE DAY)
NOVARTIS/
RTR3E41I
February 22, 2013
Swiss drugmaker Novartis CEO Joe Jimenez (L) arrives for his speech next to outgoing Chairman Daniel...
Basel, Switzerland
Swiss drugmaker Novartis CEO Jimenez arrives for his speech next to outgoing Chairman Vasella during...
Swiss drugmaker Novartis CEO Joe Jimenez (L) arrives for his speech next to outgoing Chairman Daniel Vasella during the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann (SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E40J
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (R) arrives with Ulrich Lehner, Member...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella arrives with Lehner Member of the Board of Directors...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella (R) arrives with Ulrich Lehner, Member of the Board of Directors, for the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E40I
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E40F
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella addresses the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella addresses the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E40E
February 22, 2013
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella arrives at the annual shareholders general...
Basel, Switzerland
Outgoing Chairman of Swiss drug maker Novartis Vasella arrives at the annual shareholders general meeting...
Outgoing Chairman of Swiss drug maker Novartis Daniel Vasella arrives at the annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E40D
February 22, 2013
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait...
Basel, Switzerland
A member of the Juso wearing a mask with Vasella portrait throws fake banknotes during a demonstration...
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait throws fake banknotes during a demonstration before Swiss drug maker Novartis annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH CIVIL UNREST)
NOVARTIS/
RTR3E40C
February 22, 2013
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait...
Basel, Switzerland
A member of the Juso wearing a mask with Vasella portrait throws fake banknotes during a demonstration...
A member of the Youth faction of the Socialist Party (Juso) wearing a mask with Daniel Vasella portrait throws fake banknotes during a demonstration before Swiss drug maker Novartis annual shareholders general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH CIVIL UNREST)
NOVARTIS/
RTR3E406
February 22, 2013
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln...
Basel, Switzerland
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln...
A logo is pictured on a building of Swiss drug maker Novartis before its annual general meeting in Pratteln near Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
NOVARTIS/
RTR3E3ZT
February 22, 2013
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in...
Basel, Switzerland
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in...
Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in Basel February 22, 2013. Novartis scrapped plans on February 19, 2013 to pay its outgoing chairman Daniel Vasella 72 million Swiss francs ($78 million) to stop him working for rivals, bowing to mounting anger in Switzerland over executive compensation. REUTERS/Arnd Wiegmann(SWITZERLAND - Tags: BUSINESS HEALTH)
DAVOS/
RTR3DZQM
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQL
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQK
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQH
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQF
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQE
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
DAVOS/
RTR3DZQC
February 19, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. REUTERS/Denis Balibouse (SWITZERLAND - Tags: BUSINESS HEALTH HEADSHOT)
NOVARTIS-VASELLA/
RTR3DZ7F
February 19, 2013
Daniel Vasella, chairman of Swiss drugmaker Novartis, drinks coffee before the annual news conference...
Basel, Switzerland
File photo of Vasella, chairman of Swiss drugmaker Novartis, drinking coffee before the annual news conference...
Daniel Vasella, chairman of Swiss drugmaker Novartis, drinks coffee before the annual news conference in Basel, January 23, 2013. Novartis said on February 19, 2013 it would scrap a 72 million Swiss franc ($77.98 million) pay package for outgoing chairman Vasella, bowing to mounting anger in Switzerland before an investor meeting on February 22. Picture taken January 23, 2013. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS HEALTH)
DAVOS
RTR3CY04
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CY00
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZZ
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CXZY
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
DAVOS
RTR3CXZW
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZV
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZU
January 25, 2013
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos...
Davos, Switzerland
Vasella Chairman of Novartis attends annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis attends the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH HEADSHOT)
DAVOS
RTR3CXZQ
January 25, 2013
Daniel Vasella Chairman of Novartis steps over a chair on to the stage as he arrives to address delegates...
Davos, Switzerland
Vasella Chairman of Novartis arrives to address delegates during annual meeting of WEF in Davos
Daniel Vasella Chairman of Novartis steps over a chair on to the stage as he arrives to address delegates during the annual meeting of the World Economic Forum (WEF) in Davos January 25, 2013. Vasella will step down next month as chairman of Novartis after 17 years leading the Swiss drug company which on Wednesday forecast a return to growth in 2014. Vasella's resignation after 25 years with the company, 17 as chairman or CEO, came as a surprise and he makes way for 56-year-old Joerg Reinhardt, Bayer healthcare head and a former COO of Novartis. REUTERS/Denis Balibouse (SWITZERLAND - Tags: POLITICS BUSINESS HEALTH)
NOVARTIS/
RTR3CTXG
January 23, 2013
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist...
Basel, Switzerland
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee before an annual news conference...
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist before an annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS)
NOVARTIS/
RTR3CTXC
January 23, 2013
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference...
Basel, Switzerland
Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference...
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS)
NOVARTIS/
RTR3CTX9
January 23, 2013
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist...
Basel, Switzerland
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee before an annual news conference...
Daniel Vasella, chairman of Swiss drugmaker Novartis, stirs a cup of coffee as he speaks to a journalist before an annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS)
NOVARTIS/
RTR3CTX7
January 23, 2013
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference...
Basel, Switzerland
Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference...
Daniel Vasella, chairman of Swiss drugmaker Novartis, speaks to a journalist before the annual news conference in Basel January 23, 2013. Vasella, a former chief executive who has served as Novartis as chairman for 17 years, said January 23, 2013 he would not stand for re-election to the board of directors. REUTERS/Michael Buholzer (SWITZERLAND - Tags: BUSINESS)
NOVARTIS/PROTESTS
RTR2TD9K
October 29, 2011
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the...
RISCH, Switzerland
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa...
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
NOVARTIS/PROTESTS
RTR2TD9H
October 29, 2011
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the...
RISCH, Switzerland
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa...
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
NOVARTIS/PROTESTS
RTR2TD9F
October 29, 2011
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the...
RISCH, Switzerland
Juso members demonstrate in front of Novartis Chairman of the Board Vasella's villa during "occupy villa...
Youth faction of the Socialist Party (Juso) members demonstrate in front of Novartis Chairman of the Board Daniel Vasella's villa during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
NOVARTIS/PROTESTS
RTR2TD9D
October 29, 2011
Novartis Chairman of the Board Daniel Vasella gets a placard as he talks with youth faction of the Socialist...
RISCH, Switzerland
Novartis Chairman of the Board Vasella talks with Juso protesters during "occupy villa Vasella" protest...
Novartis Chairman of the Board Daniel Vasella gets a placard as he talks with youth faction of the Socialist Party (Juso) protesters during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
NOVARTIS/PROTESTS
RTR2TD9B
October 29, 2011
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board...
RISCH, Switzerland
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board...
A cameraman films as police officers secure the access to the villa of Novartis Chairman of the Board Daniel Vasella during a youth faction of the Socialist Party (Juso) "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
NOVARTIS/PROTESTS
RTR2TD99
October 29, 2011
Novartis Chairman of the Board Daniel Vasella talks with youth faction of the Socialist Party (Juso)...
RISCH, Switzerland
Novartis Chairman of the Board Vasella talks Juso protesters during "occupy villa Vasella" protest action...
Novartis Chairman of the Board Daniel Vasella talks with youth faction of the Socialist Party (Juso) protesters during "occupy villa Vasella" protest action in Risch near Zug, October 29, 2011. Juso demonstrators gather outside the villa of Novartis AG Chairman Vasella on Saturday in protest at hefty job cuts planned by the Swiss pharmaceutical company. Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday. REUTERS/Christian Hartmann (SWITZERLAND - Tags: HEALTH BUSINESS EMPLOYMENT CIVIL UNREST)
DAVOS/
RTXX878
January 29, 2011
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in...
Davos, Switzerland
Novartis Chairman of the Board Vasella attends a session at the World Economic Forum in Davos
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS)
DAVOS/
RTXX873
January 29, 2011
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in...
Davos, Switzerland
Novartis Chairman of the Board Vasella attends a session at the World Economic Forum in Davos
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS)
DAVOS/
RTXX860
January 29, 2011
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in...
Davos, Switzerland
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum in Davos
Novartis Chairman of the Board Daniel Vasella attends a session at the World Economic Forum (WEF) in Davos January 29, 2011. Organisers and CEOs at the annual Davos meeting projected cautious confidence in the global economy as the event opened on Wednesday, pointing to numerous risks which could yet derail a still-fragile recovery. REUTERS/Christian Hartmann (SWITZERLAND - Tags: POLITICS BUSINESS)
SWITZERLAND/
RTR2AXW6
February 26, 2010
Daniel Vasella, Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis gives an...
Basel, Switzerland
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address...
Daniel Vasella, Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY)
SWITZERLAND/
RTR2AXW0
February 26, 2010
Daniel Vasella (R), Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis reacts...
Basel, Switzerland
Novartis Chairman Vasella reacts next to new CEO Jimenez as they attend their annual general meeting...
Daniel Vasella (R), Chairman and former Chief Executive Officer (CEO) of Swiss drugmaker Novartis reacts as he stands next to new CEO Joe Jimenez during his address at the annual general meeting in Basel February 26, 2010. Jimenez started in his new position on February 1, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY)
SWITZERLAND/
RTR2AXS6
February 26, 2010
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address...
Basel, Switzerland
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address...
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH)
SWITZERLAND/
RTR2AXRW
February 26, 2010
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis talks to...
Basel, Switzerland
Novartis Chairman Vasella and CEO Jimenez chat prior their annual general meeting in Basel
Daniel Vasella (R), Chairman and former Chief Executive Officer of Swiss drugmaker Novartis talks to his new CEO, Joe Jimenez, prior to their annual general meeting in Basel February 26, 2010. Jimenez started in his new position on February 1, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY)
SWITZERLAND/
RTR2AXRK
February 26, 2010
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address...
Basel, Switzerland
Daniel Vasella, Chairman and former CEO of Swiss drugmaker Novartis gives an address at the annual general...
Daniel Vasella, Chairman and former Chief Executive Officer of Swiss drugmaker Novartis gives an address at the annual general meeting in Basel February 26, 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS SOCIETY)
Sort by
Display
Items per page
Page
of 3